Skip to content
mapperlab
← Dashboard
Stock

MXCT

MaxCyte, Inc.
Latest close $1.066 of 27 marquee funds currently hold1 CUSIP mapped
Current holders
6
27 funds tracked
Ever held
8
Current + past
New this quarter
0
Exited this quarter
1

Marquee-fund ownership over time

Nov 15, 2021Aug 9, 2024Nov 14, 2025May 15, 2026
Now
6

This quarter's activity

New positions opened

None.

Positions exited

Current holders

Sorted by tenure (longest first)
FundEntry priceLatest closeReturn on entry
Renaissance Technologies$4.18$1.06-75%
Citadel Advisors$3.95$1.06-73%
Two Sigma Investments re-entered$3.95$1.06-73%
AQR Capital Management$3.95$1.06-73%
Millennium Management$3.95$1.06-73%
D.E. Shaw$3.44$1.06-69%

“Return on entry” is the price-only move from the fund's first disclosure to today — it ignores any adds, trims, or dividends. A fund that built its position over multiple quarters has a true cost basis somewhere between entry price and latest close; this figure is the upper bound.

Past holders

Funds that exited at some point
FundEntry → ExitReturn
Point72 Asset Management→ $1.04-34%
D1 Capital Partners→ $5.75-52%

Insider activity

Form 4 — officers, directors, 10%+ owners

Filed within two business days of each transaction by anyone with material insider status at MAXCYTE, INC.. Pair with the holders table above as a sanity check: heavy insider buying alongside marquee-fund accumulation is the strongest accumulation signal; heavy insider selling alongside fund exits is the strongest distribution signal.

Filings · last 30d
4
Filings · last 90d
4
Total on file
134
Recent SEC buffer
Most recent
Apr 17, 2026

30d / 90d windows measured from Apr 17, 2026 — the most recent Form 4 on file — not from today.

Showing 15 of 134 recent Form 4 filings. Browse all on EDGAR ↗

Fundamentals

XBRL · MaxCyte, Inc.

Annual figures sourced directly from MaxCyte, Inc.'s 10-K / 10-Q filings via SEC EDGAR XBRL. Latest fiscal year and the year-over-year change, with up to ten years of history.

Revenue
$33.03M
FY2025-15% YoY
Net income
-$44.63M
FY2025-9% YoY
EPS (diluted)
$-0.4200
FY2025-8% YoY
Free cash flow(?)
-$36.18M
FY2025-24% YoY

Recent SEC filings

10-K · 10-Q · 8-K · 13D/G · proxy

The most recent material filings for MAXCYTE, INC. — earnings, material events, ownership disclosures, proxy statements. Form 4 insider activity is shown in the panel above.

Trade history

Every open→close lifecycle across tracked funds
FundOpen dateClose dateOpen priceClose price / currentReturn
Two Sigma InvestmentsQ1 2026open$0.70$1.06+51%
Point72 Asset ManagementQ4 2025Q2 2026$1.58$1.04-34%
D.E. ShawQ4 2024open$3.44$1.06-69%
Citadel AdvisorsQ3 2024open$3.95$1.06-73%
Two Sigma InvestmentsQ3 2024Q4 2024$3.95$3.44-13%
AQR Capital ManagementQ3 2024open$3.95$1.06-73%
Millennium ManagementQ3 2024open$3.95$1.06-73%
Renaissance TechnologiesQ3 2024open$4.18$1.06-75%
D1 Capital PartnersQ4 2021Q3 2022$12$5.75-52%
Caveats
  • Covers only the 27 marquee funds tracked here, not the full institutional universe. A “0 holders” reading does not mean unowned.
  • Heavy funds (Renaissance Technologies, Citadel Advisors, Soros Fund Management, Two Sigma Investments, D.E. Shaw, AQR Capital Management, Millennium Management, Point72 Asset Management) use 8-quarter snapshots, so their pre-2024 history is missing.
  • “Current” reflects each fund's most recent 13F — filings lag the actual trade by up to 45 days; positions shown may have changed since.
  • Cost = price at the entry filing date. Re-entered positions show the most recent open lot.
  • Options, ADRs, and unmapped CUSIPs are excluded from the follower-backtest pipeline that produces these snapshots, so certain holding types won't appear here.